Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-12 to 2024-02-13
Current total value of award: $128.5
Description: 4563627531!DEXTROSE 5%-0.9% NACL IV SOLN 1000ML